Cars.com
CARS
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
Teradata Corp
TDC
Workday
WDAY
US Stock MarketDetailed Quotes
ARVN Arvinas
- 8.390
- -9.170-52.22%
Trading Mar 11 11:23 ET
577.00MMarket Cap-3.03P/E (TTM)
10.776High7.914Low9.18MVolume10.580Open17.560Pre Close81.85MTurnover17.10%Turnover RatioLossP/E (Static)68.77MShares45.03052wk High1.03P/B450.48MFloat Cap7.91452wk Low--Dividend TTM53.69MShs Float108.465Historical High--Div YieldTTM16.30%Amplitude7.914Historical Low8.916Avg Price1Lot Size
Arvinas Stock Forum
Sign in to post a comment
$Arvinas (ARVN.US)$ What happen bruh
1
$Arvinas (ARVN.US)$
First-Ever PROTAC Cancer Drug Hits Major Trial Milestone: What This Means
First-Ever PROTAC Cancer Drug Hits Major Trial Milestone: What This Means
Arvinas' high P/S ratio could be worrisome as revenue forecasts are not promising. The anticipated future revenues may not sustain the current positive sentiment. Without significant improvements, these prices may not be deemed reasonable.
1
Sean Cassidy expressed confidence in the company's future and the promising clinical development and commercial opportunity for the PROTAC(R) protein degrader pipeline. The company's leadership acknowledged Cassidy's pivotal role in creating Arvinas' strong financial profile.
1
$Arvinas (ARVN.US)$ I hope everyone bought that sub 14 dip! This thing has been a beast.
1
Upgrades
• $ABM Industries (ABM.US)$ : Baird Upgrades to Outperform from Neutral - PT $50
• $American Tower Corp (AMT.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $Church & Dwight (CHD.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy (CHWY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $Centene (CNC.US)$ : Credit Suisse Upgrades to Outperform from...
• $ABM Industries (ABM.US)$ : Baird Upgrades to Outperform from Neutral - PT $50
• $American Tower Corp (AMT.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $Church & Dwight (CHD.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy (CHWY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $Centene (CNC.US)$ : Credit Suisse Upgrades to Outperform from...
16
2
Upgrades
• $Cigna Group (CI.US)$ : Cowen Upgrades to Outperform from Market Perform - PT $329 (from $242)
• $DLocal (DLO.US)$ : New Street Research Upgrades to Buy from Neutral - PT $38
• $Goodyear Tire & Rubber (GT.US)$ : CFRA Upgrades to Buy from Hold - PT $20 (from $24)
• $Match group (MTCH.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $115 (from $140)
• $Prestige Consumer Healthcare (PBH.US)$ : Oppenheimer Upgrades to Outperform from Perform - P...
• $Cigna Group (CI.US)$ : Cowen Upgrades to Outperform from Market Perform - PT $329 (from $242)
• $DLocal (DLO.US)$ : New Street Research Upgrades to Buy from Neutral - PT $38
• $Goodyear Tire & Rubber (GT.US)$ : CFRA Upgrades to Buy from Hold - PT $20 (from $24)
• $Match group (MTCH.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $115 (from $140)
• $Prestige Consumer Healthcare (PBH.US)$ : Oppenheimer Upgrades to Outperform from Perform - P...
16
12
Upgrades
• $Acutus Medical (AFIB.US)$ : BTIG Upgrades to Buy from Neutral - PT $2
• $Antero Midstream (AM.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $13 (from $12)
• $Autohome (ATHM.US)$ : Citigroup Upgrades to Buy from Neutral - PT $30
• $Fifth Third Bancorp (FITB.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $52
• $Kinder Morgan (KMI.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $21
• $MSCI Inc (MSCI.US)$...
• $Acutus Medical (AFIB.US)$ : BTIG Upgrades to Buy from Neutral - PT $2
• $Antero Midstream (AM.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $13 (from $12)
• $Autohome (ATHM.US)$ : Citigroup Upgrades to Buy from Neutral - PT $30
• $Fifth Third Bancorp (FITB.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $52
• $Kinder Morgan (KMI.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $21
• $MSCI Inc (MSCI.US)$...
10
8
Upgrades
• $Banc of California (BANC.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $Cullen/Frost Bankers (CFR.US)$: Raymond James Upgrades to Outperform from Market Perform
• $W.W. Grainger (GWW.US)$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes Inc (INVH.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp (PCB.US)$: Raymond James Upgrades to Outperform from Market Perfor...
• $Banc of California (BANC.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $Cullen/Frost Bankers (CFR.US)$: Raymond James Upgrades to Outperform from Market Perform
• $W.W. Grainger (GWW.US)$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes Inc (INVH.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp (PCB.US)$: Raymond James Upgrades to Outperform from Market Perfor...
7
1
$Arvinas (ARVN.US)$ $Lucid Group (LCID.US)$ Was it a pump and dump? Just wondering. Like an idiot I bought a little RVIN and LCID in my ROTH after they ran up 2 days ago.
What should I do now?
I only have a small amount in each so it's not a huge loss so far but I'm down around 18% in each.
Should I just hold to get back to even?
Why all of a sudden did these two evs sell off so sharply? Just wondering.
What should I do now?
I only have a small amount in each so it's not a huge loss so far but I'm down around 18% in each.
Should I just hold to get back to even?
Why all of a sudden did these two evs sell off so sharply? Just wondering.
5
6
No comment yet
In His GraceMercy : The trial results released just this morning did not reach statistical significance in ITT population. https://www.stocktitan.net/news/ARVN/arvinas-and-pfizer-announce-positive-topline-results-from-phase-3-6z8ld4zloidf.html